
24 Jan 2024
PANMURE: Arecor Therapeutics : Further Arestat validation: Sanofi acquisition of Inhibrx

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
PANMURE: Arecor Therapeutics : Further Arestat validation: Sanofi acquisition of Inhibrx
Arecor Therapeutics PLC (AREC:LON) | 77.5 0 0.0% | Mkt Cap: 29.3m
- Published:
24 Jan 2024 -
Author:
Dr Mike Mitchell | Julie Simmonds -
Pages:
4 -